Nyrada Inc
NYR
Company Profile
Business description
Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.
Contact
828 Pacific Highway
Suite 2, Level 3
GordonNSW2072
AUST: +61 294983390
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,637.80 | 12.90 | 0.15% |
CAC 40 | 7,779.72 | 8.38 | -0.11% |
DAX 40 | 23,933.23 | 104.96 | -0.44% |
Dow JONES (US) | 42,093.36 | 5.34 | -0.01% |
FTSE 100 | 8,716.45 | 9.56 | -0.11% |
HKSE | 23,573.38 | 315.07 | 1.35% |
NASDAQ | 19,146.41 | 45.47 | 0.24% |
Nikkei 225 | 38,432.98 | 710.58 | 1.88% |
NZX 50 Index | 12,281.31 | 80.95 | -0.65% |
S&P 500 | 5,899.22 | 10.67 | 0.18% |
S&P/ASX 200 | 8,409.80 | 12.90 | 0.15% |
SSE Composite Index | 3,363.45 | 23.51 | 0.70% |